Certified by Founder Lodge
Apnimed
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $62,500,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 04 ,2022 | Series C | $62,500,000 |
Alpha Wave Global, LP
Sectoral Asset Management
NexPoint
Molecule
Onsetto | $2,200,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
